Aethlon shareholders approve tenfold share authorization increase
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
Aethlon Medical shareholders approved an amendment raising authorized common stock from 20 million to 200 million shares, effective October 7, 2026. The company says the expansion gives it greater flexibility for future capital raising, corporate transactions or incentive programs. Analysts rate AEMD a Hold with a Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context